<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Churchill Clinic</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where The Churchill Clinic is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601023U0&amp;denomIds=6.1.2&amp;selectedTab=summary">Nateglinide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Other antidiabetic drugs</td>
      <td>856</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>24.17</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601023U0AAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Nateglinide 60mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Intermediate and long-acting insulins</td>
      <td>193</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0406000AA&amp;denomIds=4.6&amp;selectedTab=summary">Doxylamine succinate/pyridoxine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>13</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>252</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>9.52</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0406000AAAAABAB&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Doxylamine 10mg / Pyridoxine 10mg gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0406000AABCAAAB&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Xonvea 10mg/10mg gastro-resistant tablets : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0409010AB&amp;denomIds=4.9.1&amp;selectedTab=summary">Opicapone</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>184</td>
      <td>0.11</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>6.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0409010ABAAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Opicapone 50mg capsules : 20</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0606020X0&amp;denomIds=6.6.2&amp;selectedTab=summary">Strontium ranelate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Bisphosphonates and other drugs</td>
      <td>331</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.55</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0606020X0AAAAAA&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Strontium ranelate 2g granules sachets sugar free : 3</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Churchill Clinic is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=1305030C0&amp;denomIds=13.5.3&amp;selectedTab=summary">Tacrolimus</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Drugs affecting the immune response</td>
      <td>1</td>
      <td>0.0</td>
      <td>0.81</td>
      <td>0.21</td>
      <td>-3.91</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGuUlEQVR4nO3dXYgd5R3H8e/krUmMCY1pUurbJCFpmxZTLURjm5gg6sVgBK/aUuhFiuQqUnrRKUXoRZWBIii2IEJFBS+kF5bWwbdAYlRMFEtREmib0slbi2mzSdzmxbz9e/E8w86enF2ze/acmdnn94GHOXsgM//dnN/OM88882xkZohIGGbUXYCIDI4CLxIQBV4kIAq8SEAUeJGAKPAiAVHgRQKiwIsERIEXCYgCLxKQ3gIfRZqXK9Iis+ouQETGF6f5auBJYBkQFVly62T3pcCLNFic5j8AHgV+AuwFFvWyPwVepKHiNP8+8FNgQ5ElR/zb/+5ln1FPj8dGkWEW9VKAiFwpTvPbgN8DG4ssOTpV+9UovUjDxGm+BHgJ+OFUhh10hhdplDjNI+BlYEeRJb+Z6v3rDC/SLD8GZgO/7cfOdYYXaQh/++01YH2RJZ/04xg6w4s0QJzmc4AXge39Cjso8CJN8UvggyJLXunnQXQfXqRmcZpvArYA6/p9LAVepEb+uv1Z4IEiS870+3jq0ovUJE7zpcAfgW1Flnw8iGMq8CI1iNN8BbADyIoseWNQx1XgRQYsTvO7cWH/RZElzw3y2LqGFxkAP4NuHfAI8GXg/iJL9g26DgVeZAxxms8AvgQsqWwXA3OBOZVmwCXgom/l69nAUmA5sB74J/A48KciS2pZPEYz7SRocZrPxAXyG76tBGLgZmA+8B/f/uu3Q8A54DPgPHDB72oWMNNvy9eXgGPAYWBvkSX/G8T3NB4FXoLhu9WrgDt8Wwdcjzvz7gP2A38DDgIHiywZrqnUvlHgZVqL0zwG7gXuw4X8ILDHt/dxwQ5mbUYFXqaVOM2vBTbhAn4PcAZ4w7d3iyw5V1919VPgpdX8wNpaXMDvw12D78IF/M1+PojSRgq8tIq/Dl+B657fC2wG/gG8jnu09KMiSy7XV2GzKfDSWD7cK4FvV9rXcaPeH+DO4jun4+Bavyjw0gg+3MtxI+dluL8GHAI+rLT9RZZcGGs/Mj4FXmpRCfhm3CDbBtx97r2MDvfFumqcjhR4GRh/i6wa8OO4AbadwDtFlnxaV22hUOClb+I0vxkX7s3ARuAEowN+srbiAqXAy5Twa7J9Czdn/A7gduAUIwF/u8iSE7UVKIACLxNQeZjkK4zMP1/jt9cBf6Eyi63IklM1lSpjUOADEqf5QuBG4CbfluIeEJlX2c4FvtDR5uKeEpuNG1j7F270fF+lfRLSFNW2UuCnoTjNZwFfxXWxy7YGN830IC6sh3BPcp0BzvrtOUaeBCu3ZRsqsuSzgX4jMuUU+BbzXewbGHm0cw3wTdxZ/K+4LnbZ9hdZcr6mUqUhFPgGitN8Nu6auNquxwX5hsp2Lq57XXar9/ttoe61dKPA94EP7LXAQt+qr6ttMVcGez5uYYUh3H3qsh3FTSk9DBwBjhRZcnpg35RMCz0HPv7ZKw8z+jrwJO5+a9mGB3228bO4ysGmciBqrNfd3isHq8oljKqvO78uX88HFgARbnmjYeDTcdowo0M9BBwfxNrkEq6pWNNuAW60dx5wDbAI+KJvi4EFcZqD+4CXvwSGcB/6cv2vsl3225mMDlNnwMowdwa27G0YIwNPZxkZjDp7Fe8dZ2Sg6nxlW23d3jsNnNaTWtJkPZ3hoyh6yMyemcJ6+qpt9UL7am5bvdC+mnupt9d16R/q8d8PWtvqhfbV3LZ6oX01T7pe/SEKkYAo8CIB6TXwrbnu8dpWL7Sv5rbVC+2redL19nZbTkRaRV16kYBM6D58FEUbgTuBY2b2bBRFD+IWGTxgZi/3o8Bedan5R7h556+a2c56q7tSZ73+vaeB58xsT63FjaHLz3gD7rn4PWa2u97qrtSl3q242ZCY2RO1FjeGKIo2AdvM7Hv+663AMuAtM3v3avcz0TP8ejPLcM9EA6wys18Dqye4n0EaVbOZPQ88jVvquIlG1et/qe6qtaLP1/m52IKbyNTUSUid9c7EhedYfSWNz8x24R6CKi0xs8eA705kPxMNfOcFfxsGAEbVGEXRNcBW4IV6yvlcnT/TW3D/qd+poZar1VnzQjN7CrdufBN11jvDzH6O6622xaSyN6FBO98VWo+bGvtn3F/YXAn83cz+MJkC+q1LzduBA8AOM3uvztq66azXzD703blzDe/Sd34uYuCUmf2uxtK66lLvXbhp2cNNnXEXRdFa4Fe41YRewP0ZrWXA7ol06TVKLxIQjdKLBESBFwmIAi8SEAVeJCAKvEhAFHiRgCjwIgFR4EUCosCLBESBFwmIAi8SkP8DF6GmXYpxNJYAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=1306030B0&amp;denomIds=13.6.3&amp;selectedTab=summary">Ivermectin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Topical preparation for rosacea</td>
      <td>1</td>
      <td>0.0</td>
      <td>0.88</td>
      <td>0.24</td>
      <td>-3.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=1310040Q0&amp;denomIds=13.10.4&amp;selectedTab=summary">Permethrin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Parasiticidal preparations</td>
      <td>1</td>
      <td>0.0</td>
      <td>0.84</td>
      <td>0.25</td>
      <td>-3.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601040I0&amp;denomIds=6.1.4&amp;selectedTab=summary">Glucose</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Treatment of hypoglycaemia</td>
      <td>10</td>
      <td>0.3</td>
      <td>0.75</td>
      <td>0.21</td>
      <td>-2.18</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0601040I0BBABAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoGel 40% gel original : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=G82697&amp;numIds=0202040B0&amp;denomIds=2.2.4&amp;selectedTab=summary">Co-amilofruse (Amiloride hydrochloride/frusemide)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>5</td>
      <td>0.0</td>
      <td>0.68</td>
      <td>0.33</td>
      <td>-2.07</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>